Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accrual, analgesia, announced, arrangement, Burzik, Byrd, category, Catherine, confidential, conversion, COVID, David, de, destocking, diminished, Element, Foundation, freeze, fuel, Garrison, hardware, Hickey, Instrumentation, interoperability, iv, mandatory, member, Michael, microbiology, molecular, notably, outlay, overnight, payout, PCA, PCU, president, relevant, reserve, Richard, running, satisfy, Serum, smart, SOFR, supplier, syringe, targeted, temperature, therewith, typically, Vacutainer®Trace, VencloseTM, vice, withheld
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view